A
Andrew El-Hayek
Researcher at Boston Children's Hospital
Publications - 4
Citations - 31
Andrew El-Hayek is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 1, co-authored 3 publications receiving 23 citations.
Papers
More filters
Journal ArticleDOI
Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
Adelle Dagher,Adam S. Curatolo,Monisha Sachdev,Alisa Stephens,Chris Mullins,J. Richard Landis,Adrie van Bokhoven,Andrew El-Hayek,John W. Froehlich,Andrew C. Briscoe,Roopali Roy,Roopali Roy,Jiang Yang,Jiang Yang,Michel A. Pontari,David Zurakowski,David Zurakowski,Richard S. Lee,Richard S. Lee,Marsha A. Moses,Marsha A. Moses +20 more
TL;DR: A series of candidate markers for urological chronic pelvic pain syndrome (UCPPS), selected based on their proposed involvement in underlying biological processes so as to provide new insights into pathophysiology and suggest targets for expanded clinical and mechanistic studies.
Journal ArticleDOI
Association of Longitudinal Changes in Symptoms and Urinary Biomarkers in Patients with Urological Chronic Pelvic Pain Syndrome: A MAPP Research Network Study
Roopali Roy,Roopali Roy,Alisa Stephens,Cassandra C. Daisy,Lauren Merritt,Craig Newcomb,Jiang Yang,Jiang Yang,Adelle Dagher,Adam S. Curatolo,Monisha Sachdev,Brendan McNeish,Richard Landis,Adrie van Bokhoven,Andrew El-Hayek,John W. Froehlich,John W. Froehlich,Michel A. Pontari,David Zurakowski,David Zurakowski,Richard S. Lee,Richard S. Lee,Marsha A. Moses,Marsha A. Moses +23 more
TL;DR: These urinary biomarkers may be useful in monitoring UCPPS symptom changes with respect to both urinary severity and pain severity and with further testing, they may represent objective biologic measures of U CPPS progression and/or resolution while also providing insight into the pathophysiology of UCP PS.
Proceedings ArticleDOI
Abstract 711: Mechanistic implications of COL1A1 as a prostate cancer biomarker
Andrej Jedinak,Camille Vuichoud,Andrew El-Hayek,Katherine Kaplan,Jason E. Savage,Sarah Prophet,Adam S. Feldman,Kevin Camphausen,Kevin R. Loughlin,Marsha A. Moses +9 more
TL;DR: This study analyzed and validated the presence of EGF, HE-4 and COL1A1 by enzyme-linked immunosorbent assay (ELISA) and revealed that COL 1A1 was significantly elevated in the urine of PCa patients compared to patients with BPH.
Journal ArticleDOI
Abstract 3433: Global proteomic analysis of urine using a label-free LC-MS/MS approach identifies potential biomarkers of metastatic breast cancer
Roopali Roy,Elisa M Schunkert,Petra Olivova,Martin Gilar,Scott G Geromanos,Guo-Zhong Li,John C. Gebler,Adelle Dagher,Andrew El-Hayek,Rama Aldakhlallah,David Zurakowski,Susan E. Pories,Marsha A. Moses +12 more
TL;DR: Roy et al. as mentioned in this paper performed a comparative label-free LC-MS/MS analysis of the urinary proteome of patients with metastatic breast cancer and healthy age-matched controls (HC) using a hybrid quadrupole time of flight (Q-Tof) mass spectrometer.